no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A Model for Collaboration: Sudden Death Pathway
|
Thompson, T. |
|
|
31 |
S1 |
p. S19-S20 |
article |
2 |
Analysis of Athlete QT Intervals by Age: Fridericia and Hodges Heart Rate Correction Methods Outperform the Bazett's Method for Athlete ECG Screening
|
Orchard, J. |
|
|
31 |
S1 |
p. S15 |
article |
3 |
A Young Patient With a Cardiomyopathy Caused by Mutations in the TAF1A Gene?
|
Helderman-van den Enden, A. |
|
|
31 |
S1 |
p. S8 |
article |
4 |
Bioinformatic Re-analysis of Data From the Australian Genomics Cardiovascular Genetic Disorders Flagship
|
Chang, Y. |
|
|
31 |
S1 |
p. S6 |
article |
5 |
Brugada Syndrome in New Zealand: The Experience of the National Cardiac Inherited Disease Group
|
Gelbart, D. |
|
|
31 |
S1 |
p. S7 |
article |
6 |
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) – The paediatric experience in New South Wales (NSW)
|
Fitzgerald, N. |
|
|
31 |
S1 |
p. S7 |
article |
7 |
Comparison of Methods for Correcting QT Interval in Athletes and Young People: A Systematic Literature Review
|
Mahendran, S. |
|
|
31 |
S1 |
p. S13 |
article |
8 |
Contribution and Functional Characterisation of Splice-Disrupting Variants in Inherited Heart Disease and Sudden Cardiac Death
|
Singer, E. |
|
|
31 |
S1 |
p. S2 |
article |
9 |
COPESCD — An Online Community Supporting Families After Sudden Cardiac Death in the Young: A Protocol for a Pilot Study
|
Yeates, L. |
|
|
31 |
S1 |
p. S20 |
article |
10 |
Diagnostic Yield of Panel Genetic Testing in a Cohort of >200 Patients With Congenital Heart Disease
|
Zilliacus, E. |
|
|
31 |
S1 |
p. S21 |
article |
11 |
Disproportionate Elevations of Cardiac Troponin in Fabry Disease: A Case Series of False Positives due to Macrotroponin
|
Moussa, Y. |
|
|
31 |
S1 |
p. S15 |
article |
12 |
Efficient CRISPR-editing of Pluripotent Stem Cells for Modelling CPVT in Human Cardiac Organoids
|
Pocock, M. |
|
|
31 |
S1 |
p. S16 |
article |
13 |
Embedding Genetic Counselling Into Cardiology Clinics: Case Studies From a Queensland Cardiology Genomics Service
|
Rutstein, A. |
|
|
31 |
S1 |
p. S18 |
article |
14 |
End Unexplained Cardiac Death (EndUCD) NSW Registry: A Data Linkage Cohort Study Protocol
|
Leslie, F. |
|
|
31 |
S1 |
p. S11 |
article |
15 |
Evaluating the Clinical Utility of Polygenic Risk Score for Heart Failure
|
Mo, X. |
|
|
31 |
S1 |
p. S1-S2 |
article |
16 |
Further Characterisation of the Cardiac Desminopathy Phenotype
|
Mahmoodi, E. |
|
|
31 |
S1 |
p. S13 |
article |
17 |
Genetic Basis of Childhood Cardiomyopathy
|
Bagnall, R. |
|
|
31 |
S1 |
p. S2-S3 |
article |
18 |
Genetic Testing for Pulmonary Arterial Hypertension: Diagnostic Yield and Findings From a Cohort of Patients Referred for Targeted Panel Testing
|
Hathaway, J. |
|
|
31 |
S1 |
p. S8 |
article |
19 |
Genetic Testing Outcomes in a Cohort of 21,159 Children With Heart Disease
|
Schonrock, N. |
|
|
31 |
S1 |
p. S18-S19 |
article |
20 |
Getting to the Heart of Genomics: Mainstreaming Cardiology Genomics in Queensland
|
Baldini, M. |
|
|
31 |
S1 |
p. S3 |
article |
21 |
Longitudinal CMR Assessment of Structural Phenotype in Brugada Syndrome
|
Isbister, J. |
|
|
31 |
S1 |
p. S9-S10 |
article |
22 |
miR-151-3p and miR-214 Expression Associate With Clinical Phenotypes in BAV Aortopathy
|
Portelli, S. |
|
|
31 |
S1 |
p. S16 |
article |
23 |
NSW HEARTS: The NSW Inherited Cardiomyopathy Cohort Study protocol
|
Butters, A. |
|
|
31 |
S1 |
p. S4 |
article |
24 |
Outcomes of Clinical Genetic Testing in Congenital Heart Disease – A Single-Site Audit Study
|
Morrish, A. |
|
|
31 |
S1 |
p. S14 |
article |
25 |
Patching the Gap Between Variant Identification and Risk Stratification for SCN5A-Associated Cardiac Diseases
|
Ma, J. |
|
|
31 |
S1 |
p. S12-S13 |
article |
26 |
Population Genomic Screening of Young Adults for Familial Hypercholesterolaemia: A Cost-Effectiveness Analysis
|
Lacaze, P. |
|
|
31 |
S1 |
p. S1 |
article |
27 |
Practise Changing Research – Adding DNAH11 to a Congenital Heart Disease Panel
|
Thompson, T. |
|
|
31 |
S1 |
p. S19 |
article |
28 |
Precision Medicine Opportunities for Familial Arrhythmias and Cardiomyopathies Identified When Cost of Genetic Testing is Removed as a Barrier
|
Schonrock, N. |
|
|
31 |
S1 |
p. S19 |
article |
29 |
Prevalence of Mitochondrial Genome Variants in an Inherited Heart Disease Cohort
|
Crowe, J. |
|
|
31 |
S1 |
p. S6-S7 |
article |
30 |
Reclassifying a LAMP2 Splicing Variant of Uncertain Significance to Pathogenic Following Familial Segregation and Functional RNA Diagnostics
|
Horton, A. |
|
|
31 |
S1 |
p. S9 |
article |
31 |
Recurrent GJA1 Mutation Causing Infantile Arrhythmic Cardiomyopathy Fills Gap in Knowledge of the Junction
|
Ronan, A. |
|
|
31 |
S1 |
p. S17 |
article |
32 |
Sex Disaggregated Analysis of Risk Factors for Adverse Outcomes in Hypertrophic Cardiomyopathy
|
Butters, A. |
|
|
31 |
S1 |
p. S5 |
article |
33 |
Slow Conduction Velocity Revealed in Hypertrophic Cardiomyopathy Modelled With Patient-Derived Induced Pluripotent Stem Cell Cardiomyocytes
|
Lim, S. |
|
|
31 |
S1 |
p. S11-S12 |
article |
34 |
Tango 2 Case Series: Cardiac Manifestations
|
Jardine, K. |
|
|
31 |
S1 |
p. S10 |
article |
35 |
The Congenital Heart Disease Genetics Clinic: Evolving the Model of Care
|
Morrish, A. |
|
|
31 |
S1 |
p. S14 |
article |
36 |
The Elusive Hearts Study: Seeking Genetic Diagnoses in Gene-elusive Cases of Rare Monogenic Cardiovascular Diseases
|
Richardson, E. |
|
|
31 |
S1 |
p. S17 |
article |
37 |
The Introduction and Development of a Genetic Counsellor-led Cardiac Genetics Service in a Metropolitan Hospital
|
Chalinor, H. |
|
|
31 |
S1 |
p. S5-S6 |
article |
38 |
The Role of Genetic Testing in Diagnosis and Care of Inherited Cardiac Conditions in a Specialised Multidisciplinary Clinic
|
Krishnan, N. |
|
|
31 |
S1 |
p. S10-S11 |
article |
39 |
This abstract has been withdrawn
|
|
|
|
31 |
S1 |
p. S15 |
article |
40 |
Troponin I Autoantibodies in a Patient with Desmoplakin Cardiomyopathy/Myocarditis Overlap Syndrome
|
Rowe, S. |
|
|
31 |
S1 |
p. S17-S18 |
article |
41 |
Use of Advanced Echocardiographic Modalities to Discriminate Preclinical Hypertrophic Cardiomyopathy Mutation Carriers From Non-Carriers
|
Lo, A. |
|
|
31 |
S1 |
p. S12 |
article |
42 |
Victorian Inherited Cardiac Disorders Family Initiative (VicDFI)—Creating a Shared Cardiac Clinical Database Across the Life Spectrum
|
Zentner, D. |
|
|
31 |
S1 |
p. S20-S21 |
article |